Financials
- Market Capitalization 208.1 M
- Employee 117
- Founded 1999
- CEO N/A
- Website www.niagenbioscience.com
- Headquarter Delaware, United States
- FIGI BBG000BG1J71
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
31.8
Fiyat/satışlar oranı
4.2
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3502 | SION Sionna Therapeutics, Inc. - Common Stock | 4.69 USD | -4.29% | -3.89% | -40.18% | -88.08% | 212.05 M USD | ||
| 3505 | RNAC Cartesian Therapeutics, Inc. - Common Stock | 6.99 USD | -0.99% | -2.24% | -14.65% | -23.69% | 211.48 M USD | ||
| 3529 | LYEL Lyell Immunopharma, Inc. - Common Stock | 8.27 USD | -5.05% | -8.21% | -30.91% | -65.81% | 202.66 M USD | ||
| 3534 | SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | 72.40 USD | +0.88% | -8.30% | +9.33% | +90.53% | 201.72 M USD |